Brief: Aurobindo Pharma Curateq Receives NOC From Canada Health Authority For Biosimilar Dyrupeg
09/01/2026 11:47
Jan 9 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: CURATEQ RECEIVES NOC FROM CANADA HEALTH AUTHORITY FOR BIOSIMILAR DYRUPEG Source text: ID:nNSE4n1MtQ Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11